These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 498148

  • 1. Rationale for development of platinum analogs.
    Burchenal JH, Kalaher K, Dew K, Lokys L.
    Cancer Treat Rep; 1979; 63(9-10):1493-8. PubMed ID: 498148
    [Abstract] [Full Text] [Related]

  • 2. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM, Trader MW, Laster WR, Corbett TH, Griswold DP.
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH, O'Toole T, Kalaher K, Chisholm J.
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
    Ribaud P, Gouveia J, Bonnay M, Mathe G.
    Cancer Treat Rep; 1981 Nov; 65 Suppl 3():97-105. PubMed ID: 7049371
    [Abstract] [Full Text] [Related]

  • 5. Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.
    Prestayko AW, Bradner WT, Huftalen JB, Rose WC, Schurig JE, Cleare MJ, Hydes PC, Crooke ST.
    Cancer Treat Rep; 1979 Nov; 63(9-10):1503-8. PubMed ID: 498150
    [Abstract] [Full Text] [Related]

  • 6. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M, Balázová E, Ujházy V.
    Neoplasma; 1984 Nov; 31(6):649-53. PubMed ID: 6542968
    [Abstract] [Full Text] [Related]

  • 7. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 9. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH, Kalaher K, O'Toole T, Chisholm J.
    Cancer Res; 1977 Sep 01; 37(9):3455-7. PubMed ID: 884687
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct 01; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor activity of mixed cis-complexes of platinum(II) with ammonia and cycloalkylamines].
    Konovalova AL, Presnov MA, Chel'tsov PA, Kravchenko AN, Ivanov VB.
    Dokl Akad Nauk SSSR; 1985 Oct 01; 281(1):200-3. PubMed ID: 4039648
    [No Abstract] [Full Text] [Related]

  • 12. Platinum analogs of clinical interest.
    Hill JM, Loeb E, Pardue A, Khan A, King JJ, Aleman C, Hill NO.
    Cancer Treat Rep; 1979 Oct 01; 63(9-10):1509-13. PubMed ID: 291481
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K, Akamatsu K, Matsumoto T, Morikawa K, Honda M, Mitsui H, Koizumi M, Koizumi K, Matsuno T.
    Anticancer Res; 1989 Oct 01; 9(4):987-91. PubMed ID: 2817826
    [Abstract] [Full Text] [Related]

  • 14. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1990 Jan 01; 17(1):73-8. PubMed ID: 2404458
    [Abstract] [Full Text] [Related]

  • 15. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR, al-Baker S, Shamsuddin S, Siddik ZH.
    J Med Chem; 1997 Jan 03; 40(1):112-6. PubMed ID: 9016335
    [Abstract] [Full Text] [Related]

  • 16. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 03; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1984 Dec 03; 31(6):641-7. PubMed ID: 6395026
    [Abstract] [Full Text] [Related]

  • 18. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar 03; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
    Anderson WK, Quagliato DA, Haugwitz RD, Narayanan VL, Wolpert-DeFilippes MK.
    Cancer Treat Rep; 1986 Aug 03; 70(8):997-1002. PubMed ID: 3731155
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Aug 03; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.